Inspire Medical Systems (NYSE:INSP) Issues Quarterly Earnings Results

Inspire Medical Systems (NYSE:INSP) posted its quarterly earnings results on Monday. The company reported $1.15 EPS for the quarter, topping the consensus estimate of $0.74 by $0.41, Zacks reports. Inspire Medical Systems had a net margin of 4.37% and a return on equity of 5.30%.

Inspire Medical Systems Stock Up 1.2 %

NYSE:INSP opened at $183.17 on Wednesday. Inspire Medical Systems has a fifty-two week low of $123.00 and a fifty-two week high of $257.40. The stock has a market cap of $5.49 billion, a PE ratio of 171.18 and a beta of 1.32. The firm’s fifty day simple moving average is $189.39 and its 200-day simple moving average is $191.39.

Wall Street Analysts Forecast Growth

INSP has been the subject of several research reports. KeyCorp reiterated an “overweight” rating and issued a $234.00 price target (down previously from $236.00) on shares of Inspire Medical Systems in a research report on Friday, January 24th. Bank of America upgraded shares of Inspire Medical Systems from a “neutral” rating to a “buy” rating and upped their price target for the company from $220.00 to $255.00 in a research report on Wednesday, November 20th. Morgan Stanley reduced their price target on shares of Inspire Medical Systems from $230.00 to $220.00 and set an “overweight” rating for the company in a research report on Tuesday. Wells Fargo & Company reduced their price target on shares of Inspire Medical Systems from $198.00 to $195.00 and set an “equal weight” rating for the company in a research report on Tuesday. Finally, Robert W. Baird dropped their price objective on shares of Inspire Medical Systems from $252.00 to $248.00 and set an “outperform” rating on the stock in a research note on Tuesday. Three equities research analysts have rated the stock with a hold rating and eight have given a buy rating to the company. Based on data from MarketBeat.com, Inspire Medical Systems currently has a consensus rating of “Moderate Buy” and a consensus price target of $228.82.

Inspire Medical Systems Company Profile

Inspire Medical Systems, Inc, a medical technology company, focuses on the development and commercialization of minimally invasive solutions for patients with obstructive sleep apnea (OSA) in the United States and internationally. The company offers Inspire system, a neurostimulation technology that provides a safe and effective treatment for moderate to severe OSA.